BioGaia AB Statistics
Total Valuation
BioGaia AB has a market cap or net worth of EUR 909.40 million. The enterprise value is 842.95 million.
| Market Cap | 909.40M |
| Enterprise Value | 842.95M |
Important Dates
The next estimated earnings date is Thursday, February 12, 2026.
| Earnings Date | Feb 12, 2026 |
| Ex-Dividend Date | May 8, 2025 |
Share Statistics
| Current Share Class | 98.50M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.08% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 4.19% |
| Owned by Institutions (%) | 44.13% |
| Float | 70.71M |
Valuation Ratios
The trailing PE ratio is 31.83 and the forward PE ratio is 25.48.
| PE Ratio | 31.83 |
| Forward PE | 25.48 |
| PS Ratio | 6.87 |
| PB Ratio | 8.25 |
| P/TBV Ratio | 9.42 |
| P/FCF Ratio | 31.18 |
| P/OCF Ratio | 30.92 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.92, with an EV/FCF ratio of 28.90.
| EV / Earnings | 29.50 |
| EV / Sales | 6.32 |
| EV / EBITDA | 20.92 |
| EV / EBIT | 19.78 |
| EV / FCF | 28.90 |
Financial Position
The company has a current ratio of 6.27
| Current Ratio | 6.27 |
| Quick Ratio | 4.15 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 166.59 |
Financial Efficiency
Return on equity (ROE) is 22.26% and return on invested capital (ROIC) is 20.57%.
| Return on Equity (ROE) | 22.26% |
| Return on Assets (ROA) | 17.21% |
| Return on Invested Capital (ROIC) | 20.57% |
| Return on Capital Employed (ROCE) | 35.60% |
| Revenue Per Employee | 555,788 |
| Profits Per Employee | 120,062 |
| Employee Count | 225 |
| Asset Turnover | 0.86 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BioGaia AB has paid 7.80 million in taxes.
| Income Tax | 7.80M |
| Effective Tax Rate | 21.44% |
Stock Price Statistics
The stock price has decreased by -2.08% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -2.08% |
| 50-Day Moving Average | 9.34 |
| 200-Day Moving Average | 9.41 |
| Relative Strength Index (RSI) | 40.57 |
| Average Volume (20 Days) | 21 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioGaia AB had revenue of EUR 132.28 million and earned 28.57 million in profits. Earnings per share was 0.28.
| Revenue | 132.28M |
| Gross Profit | 96.18M |
| Operating Income | 42.24M |
| Pretax Income | 36.37M |
| Net Income | 28.57M |
| EBITDA | 39.14M |
| EBIT | 42.24M |
| Earnings Per Share (EPS) | 0.28 |
Balance Sheet
The company has 65.86 million in cash and n/a in debt, giving a net cash position of 65.86 million.
| Cash & Cash Equivalents | 65.86M |
| Total Debt | n/a |
| Net Cash | 65.86M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 110.17M |
| Book Value Per Share | 1.09 |
| Working Capital | 83.58M |
Cash Flow
In the last 12 months, operating cash flow was 29.41 million and capital expenditures -249,825, giving a free cash flow of 29.16 million.
| Operating Cash Flow | 29.41M |
| Capital Expenditures | -249,825 |
| Free Cash Flow | 29.16M |
| FCF Per Share | n/a |
Margins
Gross margin is 72.71%, with operating and profit margins of 31.93% and 21.60%.
| Gross Margin | 72.71% |
| Operating Margin | 31.93% |
| Pretax Margin | 27.50% |
| Profit Margin | 21.60% |
| EBITDA Margin | 29.59% |
| EBIT Margin | 31.93% |
| FCF Margin | 22.05% |
Dividends & Yields
This stock pays an annual dividend of 0.63, which amounts to a dividend yield of 6.99%.
| Dividend Per Share | 0.63 |
| Dividend Yield | 6.99% |
| Dividend Growth (YoY) | 6.92% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 61.13% |
| Buyback Yield | -0.08% |
| Shareholder Yield | 6.90% |
| Earnings Yield | 3.14% |
| FCF Yield | 3.21% |
Stock Splits
The last stock split was on May 18, 2022. It was a forward split with a ratio of 5.
| Last Split Date | May 18, 2022 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |